Management of Uttana vatarakta (limited cutaneous systemic sclerosis): An experience through Ayurveda management strategies

Ekta Sutaria, Devendrasingh Rajput, M. Anagha, Darshna Pandya
{"title":"Management of Uttana vatarakta (limited cutaneous systemic sclerosis): An experience through Ayurveda management strategies","authors":"Ekta Sutaria, Devendrasingh Rajput, M. Anagha, Darshna Pandya","doi":"10.4103/jacr.jacr_46_22","DOIUrl":null,"url":null,"abstract":"Scleroderma (systemic sclerosis) is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Diffuse cutaneous scleroderma and Limited Cutaneous Systemic Sclerosis (LcSSC) are the two major classifications of it. LcSSc usually affects the skin and further spreads to muscles and joints, but in about 10% cases, involvement of internal organs like gastrointestinal tract and manifestations like pulmonary hypertension is seen even after 10–15 years. The prevalence of the disease is 17.6/100,000 population. As far as the management of LcSSC in conventional medicine is concerned, other than symptomatic relief; immunosuppressive drugs are given, but long-term use of such medicines suppresses the immunity of the patient and hence the patient may get affected with opportunistic infections and causes severe complications. Hence, some alternatives in this direction are being explored from other systems of medicines for the betterment of patients. The direct description of the disease scleroderma is not available in Ayurvedic literature, but based on its presentation, it can be correlated with different stages of Vatarakta (~rheumatism due to blood tissue). A 20-year-old young male patient with presentation of limited scleroderma managed with Ayurveda therapy by Virechana (~therapeutic purgation) followed by Shamana (~palliative) therapy for one and half months and obtained encouraging results, inferring that Ayurveda therapeutic protocols can be successfully adopted in cases like LcSSC.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"6 1","pages":"125 - 130"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jacr.jacr_46_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Scleroderma (systemic sclerosis) is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Diffuse cutaneous scleroderma and Limited Cutaneous Systemic Sclerosis (LcSSC) are the two major classifications of it. LcSSc usually affects the skin and further spreads to muscles and joints, but in about 10% cases, involvement of internal organs like gastrointestinal tract and manifestations like pulmonary hypertension is seen even after 10–15 years. The prevalence of the disease is 17.6/100,000 population. As far as the management of LcSSC in conventional medicine is concerned, other than symptomatic relief; immunosuppressive drugs are given, but long-term use of such medicines suppresses the immunity of the patient and hence the patient may get affected with opportunistic infections and causes severe complications. Hence, some alternatives in this direction are being explored from other systems of medicines for the betterment of patients. The direct description of the disease scleroderma is not available in Ayurvedic literature, but based on its presentation, it can be correlated with different stages of Vatarakta (~rheumatism due to blood tissue). A 20-year-old young male patient with presentation of limited scleroderma managed with Ayurveda therapy by Virechana (~therapeutic purgation) followed by Shamana (~palliative) therapy for one and half months and obtained encouraging results, inferring that Ayurveda therapeutic protocols can be successfully adopted in cases like LcSSC.
Uttana vatarakta(局限性皮肤系统硬化症)的管理:通过阿育吠陀管理策略获得的经验
硬皮病(系统性硬化症)是一组罕见疾病,涉及皮肤和结缔组织的硬化和紧绷。弥漫性皮肤硬皮病和局限性皮肤系统性硬化症(LcSSC)是它的两种主要分类。局限性皮肤系统硬化症通常影响皮肤,并进一步扩散到肌肉和关节,但约有 10%的病例甚至在 10-15 年后才出现胃肠道等内脏器官受累和肺动脉高压等表现。该病的发病率为 17.6/100,000。就传统医学对 LcSSC 的治疗而言,除了缓解症状外,还给予免疫抑制剂,但长期使用这类药物会抑制患者的免疫力,因此患者可能会受到机会性感染并引起严重的并发症。因此,为了更好地造福患者,我们正在从其他药物系统中探索一些替代方案。阿育吠陀文献中没有关于硬皮病的直接描述,但根据其表现形式,可以将其与 Vatarakta(~血液组织引起的风湿病)的不同阶段联系起来。一名 20 岁的年轻男性患者表现为局限性硬皮病,在接受阿育吠陀疗法治疗一个半月后,接受了 Virechana(治疗性净化)和 Shamana(缓解性)疗法,并取得了令人鼓舞的效果,由此推断阿育吠陀疗法方案可成功用于 LcSSC 等病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信